Abstract:Transforming growth factor-β (TGF-β) family signaling controls diverse developmental processes and the pathogenesis of many diseases, including cancer and autoimmune and fibrotic diseases. TGF-β and related proteins signal through heteromeric serine-threonine kinase receptors at the cell surface and intracellular effectors called Smads. Advancement in the knowledge of Smads as key TGF-β signal transducers and transcription factors has made it possible to establish a comprehensive model for how the conceptually simple Smad signaling pathways control a broad range of cellular responses in response to a large family of TGF-β ligands (Derynck and Zhang 2003; Shi and Massague 2003; ten Dijke and Hill 2004; Feng and Derynck 2005). Smads orchestrate the transcription of specific gene networks through interactions with cooperating sequence-specific DNA-binding transcription factors, specific DNA response elements, and non-DNA-binding transcription coactivators or corepressors that act to modify local chromatin structure and/or engage the basal transcription machinery (Fig. 1) (for reviews, see Feng and Derynck 2005; Massague et al. 2005). Recent findings also suggest that the regulation of Smad activity through posttranslational modifications such as (de)phosphorylation, ubiquitylation, and sumoylation controls the magnitude and duration of TGF-β responses (Fig. 2) (for reviews, see Feng and Lin 2006; Schilling et al. 2006). This mechanism allows for specific yet robust gene activation or repression in response to TGF-β in a context-dependent manner. This chapter spotlights the properties of Smads as transcription factors. DNA-BINDING PROPERTIES OF SMADS Transcriptional activation is a highly regulated process requiring the rigorous interactions of DNA-binding transcription factors, coactivator proteins, and general transcription...

Activation of Transforming Growth Factor-β Signaling by SUMO-1 Modification of Tumor Suppressor Smad4/DPC4*

Sumo-1/Ubc9 Promotes Nuclear Accumulation And Metabolic Stability Of Tumor Suppressor Smad4

Posttranslational Regulation of Smads

SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-β Responses*

Regulation of Smad4 Sumoylation and Transforming Growth Factor-β Signaling by Protein Inhibitor of Activated STAT1

SUMOylation of Smad2 mediates TGF-β-regulated endothelial-mesenchymal transition

Regulation of Smad Functions Through Ubiquitination and Sumoylation Pathways

The Tumor Suppressor Smad4/Dpc4 and Transcriptional Adaptor Cbp/P300 Are Coactivators for Smad3 in Tgf-Beta-Induced Transcriptional Activation

SUMOylation mediates the disassembly of the Smad4 nuclear export complex via RanGAP1 in KELOIDS

Post‐translational Regulation of TGF‐β Receptor and Smad Signaling

Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination

Post-translational regulation of TGF-β receptor and Smad signaling.

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-β signaling

Sumoylation Enhances the Activity of the TGF-β/SMAD and HIF-1 Signaling Pathways in Keloids

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling.

Phosphorylation of Ser465 and Ser467 in the C Terminus of Smad2 Mediates Interaction with Smad4 and is Required for Transforming Growth Factor-β Signaling

Usp4 Inhibits Smad4 Monoubiquitination and Promotes Activin and Bmp Signaling

Signaling of Transforming Growth Factor‐β Family Members Through Smad Proteins

Role of SUMOylation in Regulation of TGF-β Signaling Pathway

10 Transcriptional Control Via Smads